Bain Capital Life Sciences Fund II L.P. 13D and 13G filings for Savara Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-12 5:26 pm Purchase | 2024-04-10 | 13D | Savara Inc. SVRA | Bain Capital Life Sciences Fund II L.P. | 14,565,457 13.000% | 332,706 (+2.34%) | Filing |
| 2023-07-19 4:30 pm Purchase | 2023-07-17 | 13D | Savara Inc. SVRA | Bain Capital Life Sciences Fund II L.P. | 14,232,751 13.000% | 2,610,153 (+22.46%) | Filing |
| 2021-03-17 4:15 pm Purchase | 2021-03-15 | 13D | Savara Inc. SVRA | Bain Capital Life Sciences Fund II L.P. | 11,622,598 13.000% | 6,494,005 (+126.62%) | Filing |